ATE536167T1 - Zusammensetzung zur förderung der kollagenproduktion - Google Patents

Zusammensetzung zur förderung der kollagenproduktion

Info

Publication number
ATE536167T1
ATE536167T1 AT04792515T AT04792515T ATE536167T1 AT E536167 T1 ATE536167 T1 AT E536167T1 AT 04792515 T AT04792515 T AT 04792515T AT 04792515 T AT04792515 T AT 04792515T AT E536167 T1 ATE536167 T1 AT E536167T1
Authority
AT
Austria
Prior art keywords
collagen production
promoting collagen
composition
nucleic acid
related substance
Prior art date
Application number
AT04792515T
Other languages
English (en)
Inventor
Shigeo Shinohara
Mitsuaki Kawamura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE536167T1 publication Critical patent/ATE536167T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT04792515T 2003-10-08 2004-10-08 Zusammensetzung zur förderung der kollagenproduktion ATE536167T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003349156 2003-10-08
PCT/JP2004/015298 WO2005034902A1 (ja) 2003-10-08 2004-10-08 コラーゲン産生促進用組成物

Publications (1)

Publication Number Publication Date
ATE536167T1 true ATE536167T1 (de) 2011-12-15

Family

ID=34430996

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04792515T ATE536167T1 (de) 2003-10-08 2004-10-08 Zusammensetzung zur förderung der kollagenproduktion

Country Status (12)

Country Link
US (1) US7557093B2 (de)
EP (1) EP1671618B1 (de)
JP (2) JP4614886B2 (de)
KR (1) KR20060132817A (de)
CN (1) CN100569213C (de)
AT (1) ATE536167T1 (de)
AU (1) AU2004279248B2 (de)
BR (1) BRPI0415229A (de)
CA (1) CA2541584C (de)
ES (1) ES2376062T3 (de)
TW (1) TW200514575A (de)
WO (1) WO2005034902A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006225271A (ja) * 2005-02-15 2006-08-31 Otsuka Pharmaceut Co Ltd シワの予防又は改善剤
JP5791227B2 (ja) * 2007-08-06 2015-10-07 大塚製薬株式会社 アデニン化合物を含有するゲル状外用組成物
KR100903654B1 (ko) 2007-10-10 2009-06-18 (주)더페이스샵코리아 하고초 추출물과 아데노신을 함유하는 화장료 조성물
CN102885708B (zh) 2008-06-09 2015-03-18 大塚制药株式会社 外用组合物
WO2011162416A1 (en) 2010-06-25 2011-12-29 Otsuka Pharmaceutical Co., Ltd. Agent for suppressing the formation of abnormal skin cells caused by exposure to light
EP2671565B1 (de) 2011-02-01 2016-09-21 Hayashibara Co., Ltd. Externes präparat für die haut
KR101781671B1 (ko) 2011-02-14 2017-09-25 제이-오일 밀스, 인코포레이티드 피부 콜라겐 산생 촉진제
JP2013193985A (ja) * 2012-03-19 2013-09-30 Kao Corp 育毛剤
JP6332902B2 (ja) * 2012-10-29 2018-05-30 株式会社ピカソ美化学研究所 美容用組成物
JP2014141475A (ja) * 2012-12-27 2014-08-07 Daiichi Sankyo Co Ltd 新規美白剤
KR101507224B1 (ko) * 2013-05-29 2015-03-30 부산대학교 산학협력단 마늘 유래 우라실을 유효성분으로 함유하는 주름 개선용 조성물
DE202014010806U1 (de) 2013-10-29 2016-09-20 Mary Kay Inc. Kosmetische Zusammensetzungen
JP7374585B2 (ja) 2017-02-08 2023-11-07 オリエンタル酵母工業株式会社 皮膚色素沈着抑制剤
JP7300988B2 (ja) 2017-07-24 2023-06-30 大塚製薬株式会社 外用組成物
KR102026365B1 (ko) * 2018-05-11 2019-11-04 주식회사 네이처인랩 우리딘 및 활성촉진 복합체를 포함하는 화장료 조성물
WO2023058731A1 (ja) 2021-10-07 2023-04-13 ヤマサ醤油株式会社 皮膚外用組成物及びその利用、並びに皮膚外用組成物原料
JPWO2023191015A1 (de) 2022-03-30 2023-10-05

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266855A (en) 1979-09-24 1981-05-12 Quantor Corporation Quick change lens system
ES8301593A1 (es) 1981-11-16 1983-01-01 Union Ind Y Agro Ganader S A U Procedimiento de obtencion de una leche humanizada adiciona-da de nucleotidos con destino a la alimentacion infantil.
ES526873A0 (es) 1982-10-27 1985-04-16 Crinos Industria Farmaco Procedimiento de obtencion de composiciones para promover el trofismo de la piel y de foliculos piliferosos relacionados
EP0256472A3 (de) 1986-08-11 1988-09-07 Lion Corporation Kosmetische Mittel zur Anwendung auf der Haut
JPS63183535A (ja) 1986-09-18 1988-07-28 Lion Corp 皮膚外用剤
US5182269A (en) 1987-09-23 1993-01-26 Crinos Industria Farmacobiologica Spa Composition for topical use having hair stimulating, anti-dandruff and anti-seborrhoic activity
JP3818674B2 (ja) * 1992-06-02 2006-09-06 三省製薬株式会社 皮膚外用剤
JPH07233037A (ja) * 1993-12-29 1995-09-05 Sansho Seiyaku Co Ltd 皮膚化粧料
US5602109A (en) 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
JPH09295915A (ja) * 1996-04-26 1997-11-18 Kikkoman Corp 皮膚化粧料
GB9701374D0 (en) 1997-01-23 1997-03-12 Univ Liverpool Purinergic agonists and antagonists
US6203805B1 (en) 1998-11-10 2001-03-20 Color Access, Inc. Topical compositions containing whey proteins
JP2001031549A (ja) * 1999-07-14 2001-02-06 Pola Chem Ind Inc 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料
JP2001278783A (ja) 2000-03-29 2001-10-10 Shiseido Co Ltd コラーゲン産生促進剤
JP3608078B2 (ja) 2000-05-11 2005-01-05 株式会社アルソア本社 コラーゲン産生促進剤、エストロゲン様作用剤、皮膚化粧料および美容食品
US6759033B2 (en) 2000-06-22 2004-07-06 Access Business Group International Llc Method for slowing the decomposition of a cosmetic composition
ES2420104T3 (es) 2001-04-13 2013-08-22 Otsuka Pharmaceutical Co., Ltd. Promotores de la captación de azúcar
DE10132338A1 (de) 2001-07-04 2003-01-16 Basf Ag Verwendung von 5'-Desoxy-5'-methylthioadenosin in hautkosmetischen Mitteln
WO2003084485A1 (fr) * 2002-04-09 2003-10-16 Otsuka Pharmaceutical Co., Ltd. Composition de proliferation cellulaire

Also Published As

Publication number Publication date
CA2541584C (en) 2013-02-26
TWI347846B (de) 2011-09-01
EP1671618A1 (de) 2006-06-21
CN1867316A (zh) 2006-11-22
CN100569213C (zh) 2009-12-16
AU2004279248A1 (en) 2005-04-21
AU2004279248B2 (en) 2011-05-12
ES2376062T3 (es) 2012-03-08
BRPI0415229A (pt) 2006-12-05
JP4614886B2 (ja) 2011-01-19
TW200514575A (en) 2005-05-01
CA2541584A1 (en) 2005-04-21
HK1093891A1 (zh) 2007-03-16
EP1671618A4 (de) 2009-11-11
EP1671618B1 (de) 2011-12-07
US20070135374A1 (en) 2007-06-14
US7557093B2 (en) 2009-07-07
KR20060132817A (ko) 2006-12-22
JP2010215648A (ja) 2010-09-30
WO2005034902A1 (ja) 2005-04-21
JPWO2005034902A1 (ja) 2006-12-21

Similar Documents

Publication Publication Date Title
TWI347846B (de)
DE602004021585D1 (de) 5,7-DIAMINOPYRAZOLOi4,3-D PYRIMIDINE ZUR VERWENDUNG IN DER BEHANDLUNG VON BLUTHOCHDRUCK
ATE376446T1 (de) Verwendung von n-hydroxyalkyl-o-benzylchitosanen zur haarbehandlung
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE60213449D1 (de) Zusammensetzungen enthaltend ein ethanolaminderivat sowie organische metallsalze
ATE556711T1 (de) Verfahren zur verbesserung der hautqualität
ATE308610T1 (de) Dreidimensionales hautmodell
ATE503454T1 (de) Kosmetische zusammensetzungen und verfahren zu ihrer verwendung zur verbesserung des ästhetischen erscheinungsbilds der haut
EP2298275A4 (de) Zusammensetzung zur topischen anwendung
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
DE60335018D1 (de) Mittel zur verhinderung von hautalterung
ITMI20051616A1 (it) Intermedio multistrato utile per la preparazione di pelle artificiale ad aspetto scamosciato e metodo di preparazione
BRPI0515518A (pt) análogos de loxapina e métodos de usos dos mesmos
NO20091517L (no) Emulsjon
WO2005000224A3 (en) Novel dermatological composition
BR0311568A (pt) Método de tratamento de cabelo e uso de uma composição
ATE363888T1 (de) Verwendung von adenosin oder einem adenosinanalogen zur glättung von feinen linien
TW200719920A (en) Topical skin care composition
BRPI0411168B1 (pt) Composição para o tratamento dos cabelos, usos da composição e método de tratamento dos cabelos.
WO2007147445A3 (de) Keratinbindende effektormoleküle und verfahren zu deren herstellung
WO2005102363A3 (en) Methods of promoting cartilage healing or cartilage integration
ATE451950T1 (de) Verfahren zur verminderung der talgproduktion und porengrösse
EP1948320A4 (de) Hautpflegezusammensetzung für die beschleunigte produkte von kollagen-proteinen und herstellungsverfahren dafür